Showing results (141-150 of 250) with videos related to
Sort By:
Pageof 25
Journal of General Internal Medicine|March 1, 1996
Effects of a physician communication intervention on patient care outcomesS K Joos, D H Hickam, G H Gordon, et al.American Journal of Clinical Oncology|October 1, 1995
Phase II trial of isotretinoin and recombinant interferon alfa-2a in metastatic colorectal carcinomaR Pazdur, B Bready, J A Ajani, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2001
Effect of food on the oral bioavailability of UFT and leucovorin in cancer patientsB Damle, F Ravandi, S Kaul, et al.Investigational New Drugs|January 1, 1994
Phase II trial of piroxantrone in metastatic gastric adenocarcinomaR Pazdur, B Bready, A J Scalzo, et al.Cancer|February 15, 1992
A phase II trial of 5-fluorouracil and recombinant alpha-2a-interferon in previously untreated metastatic gastric carcinomaR Pazdur, J A Ajani, R Winn, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2000
Phase I assessment of the pharmacokinetics, metabolism, and safety of emitefur in patients with refractory solid tumorsJ Nemunaitis, R Eager, T Twaddell, et al.International Journal of Radiation Oncology, Biology, Physics|January 1, 1988
Preoperative radiation and chemotherapy for localized squamous cell carcinoma of the esophagus: a RTOG StudyH G Seydel, L Leichman, R Byhardt, et al.Cancer|November 1, 1977
Chemotherapy of malignant fibrous histiocytoma: a Southwest Oncology Group reportC Leite, J W Goodwin, J G Sinkovics, et al.Antimicrobial Agents and Chemotherapy|March 1, 1976
Use of clindamycin in patients with liver diseaseD R Hinthorn, L H Baker, D A Romig, et al.Cancer Chemotherapy and Pharmacology|January 1, 1984
Clinical pharmacokinetics of high-dose mitomycin CR B Schilcher, J D Young, V Ratanatharathorn, et al.Pageof 25